Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Zivo Bioscience Inc fell by 1.52m. Cash Flow from Financing totalled 4.28m or 15,461.16% of revenues. In addition the company used 5.80m for operations while cash from investing was breakeven.
Cash flow per share | -5.65 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.6917 |
---|---|
Tangible book value per share | -0.6917 |
More ▼
Balance sheet in USDView more
Current ratio | 0.1725 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼